Stephen N. Oesterle

Insider Reports History

Location
One Baxter Parkway, Deerfield, IL
Signature
/s/ Kimberly Olson, as attorney-in-fact for Stephen N. Oesterle
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen N. Oesterle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BAXTER INTERNATIONAL INC Director Common Stock, $1 par value 35.8K $1.23M $34.23 May 6, 2025 Direct
Paragon 28, Inc. Director Common Stock 0 $0 $13.06 Apr 21, 2025 Direct
Paragon 28, Inc. Director Stock Option (Right to Buy) 0 Apr 21, 2025 Direct
Sigilon Therapeutics, Inc. Director Stock Option (Right to Buy) 0 $6.64 Aug 11, 2023 Direct

Insider Reports Filed by Stephen N. Oesterle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BAX BAXTER INTERNATIONAL INC May 6, 2025 1 $0 4 May 8, 2025 Director
FNA Paragon 28, Inc. Apr 21, 2025 2 $0 4 Apr 21, 2025 Director
FNA Paragon 28, Inc. May 17, 2024 1 $0 4 May 21, 2024 Director
BAX BAXTER INTERNATIONAL INC May 7, 2024 1 $0 4 May 9, 2024 Director
SGTX Sigilon Therapeutics, Inc. Aug 11, 2023 3 -$40K 4 Aug 11, 2023 Director
SGTX Sigilon Therapeutics, Inc. May 19, 2023 1 $0 4 May 22, 2023 Director
FNA Paragon 28, Inc. May 17, 2023 1 $0 4 May 19, 2023 Director
BAX BAXTER INTERNATIONAL INC May 2, 2023 1 $0 4 May 4, 2023 Director
SGTX Sigilon Therapeutics, Inc. May 26, 2022 1 $0 4 May 27, 2022 Director
FNA Paragon 28, Inc. May 18, 2022 1 $0 4 Feb 22, 2023 Director
BAX BAXTER INTERNATIONAL INC May 3, 2022 1 $0 4 May 5, 2022 Director
FNA Paragon 28, Inc. Oct 14, 2021 1 $0 4 Dec 3, 2021 Director
FNA Paragon 28, Inc. Oct 14, 2021 0 $0 3 Oct 14, 2021 Director
MAAC Montes Archimedes Acquisition Corp Sep 30, 2021 0 $0 4 Oct 4, 2021 Director
SGTX Sigilon Therapeutics, Inc. Jun 24, 2021 1 $88.6K 4 Jun 28, 2021 Director